Eli Lilly (LLY) Other Non-Current Assets (2016 - 2025)
Historic Other Non-Current Assets for Eli Lilly (LLY) over the last 17 years, with Q3 2025 value amounting to $6.4 billion.
- Eli Lilly's Other Non-Current Assets rose 2558.87% to $6.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.4 billion, marking a year-over-year increase of 2558.87%. This contributed to the annual value of $5.7 billion for FY2024, which is 1462.55% up from last year.
- According to the latest figures from Q3 2025, Eli Lilly's Other Non-Current Assets is $6.4 billion, which was up 2558.87% from $6.2 billion recorded in Q2 2025.
- In the past 5 years, Eli Lilly's Other Non-Current Assets registered a high of $6.4 billion during Q3 2025, and its lowest value of $3.6 billion during Q2 2021.
- Its 5-year average for Other Non-Current Assets is $4.8 billion, with a median of $4.7 billion in 2023.
- As far as peak fluctuations go, Eli Lilly's Other Non-Current Assets skyrocketed by 427.33% in 2024, and later skyrocketed by 2903.08% in 2025.
- Quarter analysis of 5 years shows Eli Lilly's Other Non-Current Assets stood at $4.1 billion in 2021, then rose by 6.23% to $4.3 billion in 2022, then increased by 15.05% to $5.0 billion in 2023, then increased by 14.63% to $5.7 billion in 2024, then rose by 12.46% to $6.4 billion in 2025.
- Its Other Non-Current Assets stands at $6.4 billion for Q3 2025, versus $6.2 billion for Q2 2025 and $6.1 billion for Q1 2025.